Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Low-dose Corticosteroids and Theophylline on the Risk of Acute Exacerbations of COPD: the TASCS Randomised Clinical Trial

NCT02261727 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT02261727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02261727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Low-dose Corticosteroids and Theophylline on the Risk of Acute Exacerbations of COPD: the TASCS Randomised Clinical Trial
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
May 14, 2018
Enrollment
1,670 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease